Gaku Ichihara

Prof. Gaku Ichihara


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
HNHirotaka Nagai
Hirotaka Nagai
Yasumasa OkazakiYasumasa Okazaki
Yasumasa Okazaki
SCShan Hwu Chew
Shan Hwu Chew
NMNobuaki Misawa
Nobuaki Misawa
YYYoriko Yamashita
Yoriko Yamashita
Shinya ToyokuniShinya Toyokuni
Shinya Toyokuni
Multiwalled carbon nanotubes (MWCNTs) have the potential for widespread applications in engineering and materials science. However, because of their needle-like shape and high durability, concerns have been raised that MWCNTs may induce asbestos-like pathogenicity. Although recent studies have demonstrated that MWCNTs induce various types of reactivities, the physicochemical features of MWCNTs that determine their cytotoxicity and carcinogenicity in mesothelial cells remain unclear. Here, we showed that the deleterious effects of nonfunctionalized MWCNTs on human mesothelial cells were associated with their diameter-dependent piercing of the cell membrane. Thin MWCNTs (diameter ∼ 50 nm) with high crystallinity showed mesothelial cell membrane piercing and cytotoxicity in vitro and subsequent inflammogenicity and mesotheliomagenicity in vivo. In contrast, thick (diameter ∼ 150 nm) or tangled (diameter ∼ 2–20 nm) MWCNTs were less toxic, inflammogenic, and carcinogenic. Thin and thick MWCNTs similarly affected macrophages. Mesotheliomas induced by MWCNTs shared homozygous deletion of Cdkn2a/2b tumor suppressor genes, similar to mesotheliomas induced by asbestos. Thus, we propose that different degrees of direct mesothelial injury by thin and thick MWCNTs are responsible for the extent of inflammogenicity and carcinogenicity. This work suggests that control of the diameter of MWCNTs could reduce the potential hazard to human health.

23 April 2019 in Particle and Fibre Toxicology
Verified
Journal Article
Open access
PDF file
MRMichael Riediker
Michael Riediker
DZDaniele Zink
Daniele Zink
WKWolfgang Kreyling
Wolfgang Kreyling
GOGünter Oberdörster
Günter Oberdörster
AEAlison Elder
Alison Elder
Flemming CasseeFlemming Cassee
Flemming Cassee
Particles and fibres affect human health as a function of their properties such as chemical composition, size and shape but also depending on complex interactions in an organism that occur at various levels between particle uptake and target organ responses. While particulate pollution is one of the leading contributors to the global burden of disease, particles are also increasingly used for medical purposes. Over the past decades we have gained considerable experience in how particle properties and particle-bio interactions are linked to human health. This insight is useful for improved risk management in the case of unwanted health effects but also for developing novel medical therapies. The concepts that help us better understand particles’ and fibres’ risks include the fate of particles in the body; exposure, dosimetry and dose-metrics and the 5 Bs: bioavailability, biopersistence, bioprocessing, biomodification and bioclearance of (nano)particles. This includes the role of the biomolecule corona, immunity and systemic responses, non-specific effects in the lungs and other body parts, particle effects and the developing body, and the link from the natural environment to human health. The importance of these different concepts for the human health risk depends not only on the properties of the particles and fibres, but is also strongly influenced by production, use and disposal scenarios. Lessons learned from the past can prove helpful for the future of the field, notably for understanding novel particles and fibres and for defining appropriate risk management and governance approaches.

14 March 2013 in Occupational and Environmental Medicine
Verified
Journal Article
Closed access
PDF file
SKShinji Kumagai
Shinji Kumagai
NKNorio Kurumatani
Norio Kurumatani
AAAkira Arimoto
Akira Arimoto
GIGaku Ichihara
Gaku Ichihara
Objectives The present study was conducted to investigate the relationship between occupational chemical exposure and incidence of cholangiocarcinoma among workers in the offset colour proof-printing section of a small printing company in Osaka, Japan. Methods We identified 51 men who had worked in the proof-printing room, and 11 men who had worked in the front room for at least 1 year between 1991 and 2006. We interviewed them about the chemicals they used, and estimated their levels of exposure to chemicals. We also investigated the medical records of 11 cholangiocarcinoma patients, and calculated the standardised mortality ratio (SMR) from 1991 to 2011. Results Workers used 1,2-dichloropropane (1,2-DCP) from approximately 1985 to 2006, and dichloromethane (DCM) from approximately 1985 to 1997/1998. Exposure concentrations were estimated to be 100–670 ppm for 1,2-DCP and 80–540 ppm for DCM among the proof-printing workers. All 11 patients were pathologically diagnosed with cholangiocarcinoma. Ages at diagnosis were 25–45 years, and ages at death were 27–46 years among the six deceased individuals. The primary cancer site was the intrahepatic bile duct for five patients, and the extrahepatic bile ducts for six. All patients were exposed to 1,2-DCP for 7–17 years and diagnosed with cholangiocarcinoma 7–20 years after their first exposure. Ten patients were also exposed to DCM for 1–13 years. The SMR for cholangiocarcinoma was 2900 (expected deaths: 0.00204, 95% CI 1100 to 6400) for all workers combined. Conclusions These findings suggest that 1,2-DCP and/or DCM may cause cholangiocarcinoma in humans.

1 May 2007 in Journal of Occupational Health
Verified
Journal Article
Closed access
YIYuki Ito
Yuki Ito
OYOsamu Yamanoshita
Osamu Yamanoshita
NANobuyuki Asaeda
Nobuyuki Asaeda
YTYoshiaki Tagawa
Yoshiaki Tagawa
CLChul‐Ho Lee
Chul‐Ho Lee
TNTamie Nakajima
Tamie Nakajima
Di(2‐ethylhexyl)phthalate Induces Hepatic Tumorigenesis through a Peroxisome Proliferator‐activated Receptor α‐independent Pathway: Yuki Ito, et al. Department of Occupational and Environmental Health, Nagoya University Graduate School of Medicine—Di(2ethylhexyl)phthalate (DEHP), a commonly used industrial plasticizer, causes liver tumorigenesis presumably via activation of peroxisome proliferator‐activated receptor alpha (PPARα). The mechanism of DEHP tumorigenesis has not been fully elucidated, and to clarify whether DEHP tumorigenesis is induced via PPARα, we compared DEHP‐induced tumorigenesis in wild‐type and Pparα‐null mice. Mice of each genotype were divided into three groups, and treated for 22 months with diets containing 0, 0.01 or 0.05% DEHP. Surprisingly, the incidence of liver tumors was higher in Pparα‐null mice exposed to 0.05% DEHP (25.8%) than in similarly exposed wild‐type mice (10.0%). These results suggest the existence of pathways for DEHP‐induced hepatic tumorigenesis that are independent of PPARα. The levels of 8‐OHdG increased dose‐dependently in mice of both genotypes, but the degree of increase was higher in Pparα‐null than in wild‐type mice. NFκB levels also significantly increased in a dose‐dependent manner in Pparα‐null mice. The protooncogene c‐jun‐mRNA was induced, and c‐fos‐mRNA tended to be induced only in Pparα‐null mice fed a 0.05% DEHP‐containing diet. These results suggest that increases in oxidative stress induced by DEHP exposure may lead to the induction of inflammation and/or the expression of protooncogenes, resulting in a high incidence of tumorigenesis in Pparα‐null mice.

1 September 2005 in Toxicology
Verified
Journal Article
Closed access
AOAi Okamura
Ai Okamura
MKMichihiro Kamijima
Michihiro Kamijima
ESEiji Shibata
Eiji Shibata
KOKatsumi Ohtani
Katsumi Ohtani
KTKenji Takagi
Kenji Takagi
TNTamie Nakajima
Tamie Nakajima

1 August 2006 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
SISahoko Ichihara
Sahoko Ichihara
KOKoji Obata
Koji Obata
YYYoshiji Yamada
Yoshiji Yamada
KNKohzo Nagata
Kohzo Nagata
ANAkiko Noda
Akiko Noda
MYMitsuhiro Yokota
Mitsuhiro Yokota